Federal Policy
All States Apply for CMS Medicaid Drug Pricing Program
All 50 states, Washington, D.C., and Puerto Rico have applied to participate in a CMS arrangement designed to reduce Medicaid drug costs, with 40 states and Puerto Rico already signing agreements. President Trump announced the milestone Friday, characterizing the program as delivering significant savings to state Medicaid programs. The timing and specific mechanics of the drug pricing arrangement were not detailed in the announcement. The development signals broad state interest in federal cost-containment tools for Medicaid pharmacy spending.
Why it mattersUniversal state participation in a federal Medicaid drug pricing initiative could reshape pharmacy benefit administration and rebate structures across state programs and managed care organizations.